Detection of triazolam and its hydroxy metabolites in rat hair by reversed-phase liquid chromatography with electrospray ionization mass spectrometry

Journal of Analytical Toxicology

Volumn 24, Issue 3, 2000, Pages 194-201

  Toyo'oka, Toshimasa ^a   Kanbori, Masayoshi ^a   Kumaki, Yusuke ^a   Oe, Tomoyuki ^a   Miyahara, Taketsune ^a   Nakahara, Yuji ^b  

^a UNIVERSITY OF SHIZUOKA   (Japan)

^b NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

TRIAZOLAM;

ANIMAL TISSUE; ARTICLE; DRUG DETERMINATION; DRUG MONITORING; DRUG STRUCTURE; HAIR ROOT; MASS SPECTROMETRY; NONHUMAN; RAT; REVERSED PHASE LIQUID CHROMATOGRAPHY;

AGOUTI; ANIMALIA;

EID: 0034068598     PISSN: 01464760     EISSN: None     Source Type: Journal    
DOI: 10.1093/jat/24.3.194     Document Type: Article

References (45)

1. J.J. Sramek, W.A. Baumgartner, T.N. Ahrens, V.A. Hill, and N.R. Cutler. Detection of benzodiazepines in human hair by radioimunoassay. Ann. Pharmacother. 26: 469-472 (1992).
2. P. Kintz, B. Ludes, and P. Mangin. Detection of drugs in human hair using Abbott ADx, with confirmation by gas chromatography/mass spectrometry (GC/MS). J. Forensic Sci. 37: 328-331 (1992).
3. P. Kintz, V. Cirimele, F. Vaysette, and P. Mangin. Hair analysis for nordiazepam and oxazepam by gas chromatography - negative-ion chemical ionization mass spectrometry. J. Chromatogr. B 677: 241-244 (1996).
4. M.J. Ellenhorn. Sedative-hypnotic drugs. In Ellenhorn's Medical Toxicology, 2nd ed., ch. 41. Williams and Wilkins, Baltimore, MD, 1997, pp 687-695.
5. J. Gaudreault, F. Varin, and G.M. Pollack. Anticonvulsant pharmacodynamics and disposition of triazolam in rats. J. Pharm. Sci. 85: 999-1004 (1996).
6. S.K. Gupta, E.H. Ellinwood, A.M. Nikaido, and D.G. Heatherly. Simultaneous modeling of the pharmacokinetic and pharmacodynamic properties of benzodiazepines. II. Triazolam. Pharm. Res. 7: 570-576 (1990).
7. P.D. Kroboth, R.B. Smith, T. Rosanske, D.H. Van Thiel, and R.P. Juhl. Nighttime dosing of triazolam in patients with liver disease and normal subjects: Kinetics and daytime effects. J. Clin. Pharmacol. 27: 555-560 (1987).
8. R.B. Smith, P.D. Kroboth, and P.D. Varner. Pharmacodynamics of triazolam after intravenous administration. J. Clin. Pharmacol. 27: 971-979 (1987).
9. R.P. Vanderveen, J.L. Jirak, G.R. Peters, S.R. Cox, and P.A. Bombardt. Effect of ranitidine on the disposition of orally and intravenously administered triazolam. Clin. Pharmacol. 10: 539-543 (1991).
10. J.P. Sunter, T.S. Bal, and W.K. Cowan. Three cases of fatal triazolam poisoning. Br. Med. J. 297: 719 (1988).
11. K.R. Olson, L. Yin, J. Osterloh, and A. Tani. Coma caused by trivial triazolam overdoses. Am. J. Emerg. Med. 3: 210-211 (1985).
12. R. Dixon, R. Lucek, R. Young, R. Ning, and A. Darragh. Radioimmunoassay for nitrazepam in plasma. Life Sci. 25: 311-316 (1979).
13. H. Ko, M.E. Royer, J.B. Hester, and K.T. Johnston. Radioimmunoassay of triazolam. Anal. Lett. 10: 1019-1040 (1977).
14. A.D. Fraser. Urinary screening for alprazolam, triazolam, and their metabolites with the EMIT d.a.u. benzodiazepine metabolite assay. J. Anal. Toxicol. 11: 263-266 (1987).
15. M.E. Jolly. Fluorescence polarization irnmunoassay for the determination of therapeutic drug levels in human plasma. J. Anal. Toxicol. 5:236-240 (1981).
16. A.G. de Boer, J. Röst-Kaiser, H. Bracht, and D.D. Breimer. Assay of underivatized nitrazepam and clonazepam in plasma by capillary gas chromatography applied to pharmacokinetic and bioavailability studies in human. J. Chromatogr. 145: 105-114 (1978).
17. L. Kangas. Determination of nitrazepam and its main metabolites in urine by gas-liquid chromatography: use of electron capture and nitrogen-selective detectors. J. Chromatogr. 172: 273-278 (1979).
18. B.J. 't Jart and J. Wilting. Selective gas chromatographic method for determining nitrazepam in serum and saliva. J. Chromatogr. 424: 403-409 (1988).
19. Y.C. Sumiratapura, C. Aubert, and J.P. Cano. Highly specific and sensitive method for the determination of flunitrazepam in plasma by electron gas liquid chromatography. Arzneim. Forsch. 32: 252-257 (1982).
20. D.J. Greenblatt, H.R. Ochs, A. Locniskar, and P.M. Lauven. Automated electron-capture gas chromatographic analysis of flunitrazepam in plasma. Pharmacology 24: 82-87 (1982).
21. M.D. Allen, D.J. Greenblatt, and J.D. Arnold. Single-and multiple-dose kinetics of estazolam, a triazolo-benzodiazepine. Psychopharmacology 66: 267-274 (1979).
22. M. Konishi, Y. Mori and K. Hirai. Simultaneous determination of triazolo-benzophenone 2′,5-dichloro-2-(3-glycylaminomethyl-5-methyl-4H-1,2,4-triazol-4-yl)- benzophenone and its major blood metabolite, triazolam, in monkey plasma by electron-capture gas-liquid chromatography. J. Chromatogr. 229: 355-363 (1982).
23. G. Baktir, J. Bircher, H.U. Fisch, and G. Karlaganis. Capillary gas-liquid chromatographic determination of the benzodiazepine triazolam in plasma using a retention gap. J. Chromatogr. 339: 192-197 (1985).
24. K.M. Höld, D.J. Crouch, D.G. Wilkins, D.E. Rollins, and R.A. Maes. Detection of alprazolam in hair by negative ion chemical ionization mass spectrometry. Forensic Sci. Int. 84: 201-209 (1997).
25. V. Cirimele, P. Kintz, C. Staub, and P. Mangin. Testing human hair for flunitrazepam and 7-amino-flunitrazepam by GC/MS-NCI. Forensic Sci. Int. 84:189-200 (1997).
26. V. Cirimele, P. Kintz, and B. Ludes. Screening for forensically relevant benzodiazepines in human hair by gas chromatography-negative ion chemical ionization-mass spectrometry. J. Chromatogr. B 700: 119-129 (1997).
27. M. Yegles, F. Mersch, and R. Wenning. Detection of benzodiazepines and other psychotropic drugs in human hair by GC/MS. Forensic Sci. Int. 84: 211-218 (1997).
28. H. Kelly, A. Huguett, and S. Dawling. Liquid-chromatographic measurement of nitrazepam in plasma. Clin. Chem. 28: 1478-1481 (1982).
29. P.C. Ho, E.J. Triggs, V.J. Heaziewood, and D.W. Bourne. Determination of nitrazepam and termazepam in plasma by High-performance liquid chromatography. Ther. Drug Monit. 5: 303-307 (1983).
30. K. Suzuki, I. Johno, and S. Kitazawa. High-performance liquid chromatographic determination of nitrazepam in plasma and its application to pharamacokinetic studies in the rat. J. Chromatogr. 425: 435-440 (1988).
31. Y.C. Sumirtapura, C. Aubert, P. Coassolo, and J.P. Cano. Determination of 7-amino-flunitrazepam (Ro 20-1815) and 7-aminodesmethylfluritrazepam (Ro 5-4650) in plasma by high-performance liquid chromatography and fluorescence detection. J. Chromatogr. 232: 111-118 (1982).
32. J.P. Weijers-Everhard, J. Wijker, R. Verrijik, H.H. Van Rooij, and W. Soudijn. Immproved qualitative method for establishing flunitrazepam abuse using samples and column liquid chromatography with fluorometric detection. J. Chromatogr. 374: 339-346 (1986).
33. W.J. Adams, U.M. Rykert, and P.A. Bombardt. High-performance liquid chromatographic determination of triazolam in human serum. Anal. Lett. 13: 149-161 (1980).
34. A. Boukhabza, A.A.J. Lugnier, P. Kintz, and P. Mangin. Simultaneous HPLC analysis of the hypnotic benzodiazepines nitrazepam, estazolam, flunitrazepam, and triazolam in plasma. J. Anal. Toxicol. 15: 319-322 (1991).
35. N. Senda, K. Kohta, T. Takahashi, K. Shizukuishi, T. Miura, T. Fujita, and M. Nakayama. A highly sensitive method to quantify triazolam and its metabolites with liquid chromatography-mass spectrometry. Biomed. Chromatogr. 9: 48-51 (1995).
36. R.C. Baselt and R.H. Cravey. Triazolam. In Disposition of Toxic Drugs and Chemicals in Man, 4th ed. Chemical Toxicology Institute, Foster City, CA, 1995, pp 749-751.
37. A.C. Moffat. Clarke's Isolation and Identification of Drugs, 2nd ed. The Pharmaceutical Press, London, U.K., 1986, pp 1038-1039.
38. J.B. Leikin and F.P. Paloucek. Poisoning & Toxicology Handbook. American Pharmaceutical Association, Washington, D.C., 1995, pp 638-639.
39. F.S. Eberts, Y. Philopoulos, L.M. Reineke, and R.W. Vliek. Triazolam disposition. Clin. Pharm. Ther. 29: 81-93 (1981).
40. T. Inoue and S. Suzuki. High-performance liquid chromatographic determination of triazolam and its metabolites in human urine. J. Chromatogr. 422: 197-204 (1987).
41. L.L. Von Moltke, D.J. Greenblatt, M.M. Cotreau-Bibbo, S.X. Duan, J.S. Harmatz, and R.I. Shader. Inhibition of desipramine hydroxylation in vitro by serotonin-reuptake-inhibitor antidepressants, and by quinidine and ketoconazole: a model system to predict drug interactions in vivo. J. Pharmacol. Exp. Ther. 268: 1278-1283 (1994).
42. Y. Nakahara, K. Yakahashi, and R. Kikura. Hair analysis for drugs of abuse. X. Effect of physicochemical properties of drugs on the incorporation rats into hair. Biol. Pharm. Bull. 18: 1223-1227 (1995).
43. L. Potsch, C. Skopp, and M.R. Moeller. Influence of pigmentation on the codeine content of hair fibers in guinea pigs. J. Forensic Sci. 42: 1095-1098 (1997).
44. S.P. Gygi, R.E. Joseph, Jr., E.J. Cone, D.G. Wilkins, and D.E. Rollins. Incorporation of codeine and metabolites into hair. Drug Metab. Dispos. 24: 495-501 (1996).
45. M.H. Slawson, D.G. Wilkins, R.L. Foltz, and D.E. Rollins. Quantitative determination of phencyclidine in pigmented and nonpigmented hair by ion-trap mass spectrometry. J. Anal. Toxicol. 20: 350-354 (1996).